Robin Kramer - 13 Feb 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Financial Officer
Signature
/s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Issuer symbol
BIIB
Transactions as of
13 Feb 2026
Net transactions value
$0
Form type
4
Filing time
17 Feb 2026, 20:14:49 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kramer Robin Chief Financial Officer 225 BINNEY STREET, CAMBRIDGE /s/ Wendell Taylor, attorney-in-fact for Robin Kramer 17 Feb 2026 0001609222

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +8,450 $0.000000 8,450 13 Feb 2026 Common Stock 8,450 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.